Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (37,610,384)	$ (42,942,198)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	6,848,193	7,614,321
Issuance of shares in consulting agreement	267,000	1,021,000
Amortization of debt discount	1,156,905	652,006
Depreciation expense	21,112	17,359
Operating lease expense	0	160,685
Finance lease amortization expense	38,679	39,967
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(870,294)	165,672
Accounts payable	(5,297,956)	5,763,537
Accrued expenses	416,522	(5,889,016)
Operating lease liabilities	0	(239,469)
Net cash used in operating activities	(35,030,223)	(33,636,136)
Cash flows from investing activities:
Purchase of equipment	(29,000)	0
Net cash used in investing activities	(29,000)	0
Cash flows from financing activities:
Proceeds from exercise of stock options	774,091	308,942
Payments of finance lease obligations	(55,795)	(59,300)
Payment of loan principal	(3,125,000)	0
Proceeds from issuances of common stock, net of issuance costs	22,595,001	16,126,851
Net cash provided by financing activities	20,188,297	16,376,493
Net (decrease) increase in cash and cash equivalents	(14,870,926)	(17,259,643)
Cash and cash equivalents at beginning of period	56,560,517	73,820,160
Cash and cash equivalents at end of period	41,689,591	56,560,517
Supplemental information of cash and non-cash transactions:
Cash paid for interest	$ 3,556,662	$ 3,535,071